Sun Pharma to buy US drugmaker Organon for $11.75 billion in India’s largest pharma deal

By Kashish Tandon and Rishika Sadam April 26 (Reuters) – Sun Pharmaceutical Industries will buy U.S. drugmaker Organon & Co in an all-cash deal valued at about $11.75 billion including debt, for the …